Presentation ESC 2015 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions Presenter: Takeshi Kimura September 01, 2015
Presentation ESC 2015 Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program Presenter: Marco Valgimigli September 01, 2015
News Conference News ESC 2015 UK Registry: No Relationship Between Hospital PCI Volume and Early Mortality Yael L. Maxwell September 01, 2015
News Conference News ESC 2015 Registry Provides Support for Use of MitraClip in Lower-Risk Patients L.A. McKeown September 01, 2015
News Conference News ESC 2015 Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients L.A. McKeown September 01, 2015
News Conference News ESC 2015 NSAIDs Plus Anticoagulants a Bad Combination Caitlin E. Cox September 01, 2015
News Conference News ESC 2015 Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes Yael L. Maxwell September 01, 2015
News Conference News ESC 2015 DAPT Analysis Eases Concerns Over Slightly Higher Death Rate Seen With Extended Thienopyridine Use Caitlin E. Cox September 01, 2015
Presentation ESC 2015 Long-term Dual Antiplatelet Therapy for 2° Prevention of Cardiovascular Events in Patients with Previous Myocardial Infarction Presenter: Jacob A. Udell August 31, 2015
Presentation ESC 2015 12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial Presenter: G?rard Helft August 31, 2015
News Conference News ESC 2015 TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics Yael L. Maxwell August 31, 2015
News Conference News ESC 2015 OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES Caitlin E. Cox August 31, 2015
News Conference News ESC 2015 Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients L.A. McKeown August 31, 2015
News Conference News ESC 2015 Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI Yael L. Maxwell August 31, 2015
News Conference News ESC 2015 Danish Registry Study Shows Potential of Stroke Risk Score in Heart Failure Patients L.A. McKeown August 31, 2015
News Conference News ESC 2015 Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients Caitlin E. Cox August 31, 2015
Presentation ESC 2015 Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial Presenter: Gregg W. Stone August 30, 2015
Presentation ESC 2015 CIRCUS Study: Does Cyclosporine Improve Clinical Outcome is ST-Elevation Myocardial Infarction Patients? Presenter: Michael Ovize August 30, 2015
Presentation ESC 2015 Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up Presenter: Gilles Montalescot August 30, 2015
News Conference News ESC 2015 FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP Yael L. Maxwell August 30, 2015